Report post

How has demand for weight loss drugs boosted Eli Lilly stock prices?

Demand for weight loss drugs has boosted the revenues and stock prices of Eli Lilly and Ozempic and Wegovy-maker Novo Nordisk ( NVO) over the past year. Eli Lilly shares, which have nearly doubled over the past year, gained 6.0% to finish Tuesday's session at $781.10.

What products does Eli Lilly sell?

Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology. Find the latest Eli Lilly and Company (LLY) stock quote, history, news and other vital information to help you with your stock trading and investing.

Why did Eli Lilly stock gain 6% Tuesday?

Eli Lilly shares gained 6% Tuesday as the drugmaker reported first-quarter earnings above expectations and raised full year revenue and earnings guidance. Weight-loss drugs Mounjaro and Zepbound continue to be massive revenue drivers for the company as demand has soared in recent years.

The World's Leading Crypto Trading Platform

Get my welcome gifts